The MPP And Merck Partner For Molnupiravir In Lower-Income Countries
As MPP Looks To Further License Non-Exclusive Sublicenses To Manufacturers
The Medicines Patent Pool has signed its first agreement to provide access for a COVID-19 medical technology with Merck & Co, to increase access of generic molnupiravir to 150 lower income countries.
